Outcome Measures in Multiple Sclerosis

被引：5
|
作者：
Bermel, Robert [1 ]
Waldman, Amy [2 ]
Mowry, Ellen M. [3 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44195 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA
来源：
MULTIPLE SCLEROSIS INTERNATIONAL | 2014年 / 2014卷
关键词：
D O I：
10.1155/2014/439375
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The effectiveness of Natalizumab on MRI outcome measures in patients with relapsing multiple sclerosis
    Dalton, C
    Barker, G
    MacManus, D
    Miszkiel, K
    Bates, D
    Blumhardt, L
    Hawkins, C
    Palace, J
    Sharief, M
    Swingler, R
    Young, C
    Miller, D
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (03): : 399 - 399
  • [32] Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?
    Filippi, Massimo
    Preziosa, Paolo
    Rocca, Maria A.
    CURRENT OPINION IN NEUROLOGY, 2014, 27 (03) : 290 - 299
  • [33] The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test As Outcome Measures in Pediatric-Onset Multiple Sclerosis
    Brenton, J. Nicholas
    Koshiya, Hitoshi
    Woolbright, Emma
    Gampper, Lauren
    Leytham, Emily
    Goldman, Myla D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 42 - 43
  • [34] Disability prediction in multiple sclerosis using performance outcome measures and demographic data
    Roy, Subhrajit
    Mincu, Diana
    Proleev, Lev
    Rostamzadeh, Negar
    Ghate, Chintan
    Harris, Natalie
    Chen, Christina
    Schrouff, Jessica
    Tomasev, Nenad
    Hartsell, Fletcher Lee
    Heller, Katherine
    CONFERENCE ON HEALTH, INFERENCE, AND LEARNING, VOL 174, 2022, 174 : 375 - 396
  • [35] The effect of natalizumab treatment on cytokine profiles and clinical outcome measures in multiple sclerosis
    Khademi, Mohsen
    Rafatnia, Farshid
    Andersson, Magnus
    Brundin, Lou
    Wallstroem, Erik
    Piehl, Fredrik
    Olsson, Tomas
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 143 - 143
  • [36] Utility of Physical Disability Outcome Measures in Pediatric-Onset Multiple Sclerosis
    Brenton, J. Nicholas
    Koshiya, Hitoshi
    Engel, Casey
    Herod, Sarah
    Engelhard, Matthew
    Goldman, Myla
    NEUROLOGY, 2017, 88
  • [37] Construct validity of potential multiple sclerosis clinical trial MRI outcome measures
    Cookfair, D. L.
    Benedict, R. H. B.
    Zivadinov, R.
    JOURNAL OF NEUROLOGY, 2006, 253 : 82 - 82
  • [38] Multiple sclerosis: Epidemiology, genetics, classification, natural history, and clinical outcome measures
    Wingerchuk, DM
    Weinshenker, BG
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2000, 10 (04) : 611 - +
  • [39] Monitoring the progression of the multiple sclerosis: not all the outcome measures are the same over time
    Prada, V.
    Piccardo, E.
    Bezzini, D.
    Bragadin, M. Monti
    Brichetto, G.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 406 - 406
  • [40] Social work in Multiple Sclerosis Rehabilitation: core activities, assessment and outcome measures
    Verdoodt, R.
    Denissen, S.
    Meurrens, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (07) : 1040 - 1040
12345